GLP-1 drugs are shaking things up in the market! Novo Nordisk's Ozempic is a game-changer, showing early signs of helping diabetes patients' kidneys. This news made dialysis providers like DaVita (-17%) and Fresenius Medical (-17.6%) stocks drop big time.
Ironically, these drugs could keep folks on dialysis for longer, creating short-term chances for the providers. Plus, Novo's Ozempic is on fire and could help up to 5 million patients, which is negative for consumer snack companies.
[link] [comments] https://www.reddit.com/r/stocks/comments/175yskf/glp1_drugs_sent_davita_17_lower/
Login to add comment
Other posts in this group
Please use this thread to discuss your portfolio, learn of other stock tickers, and help out users by giving constructive criticism.
Why quarterly? Public comp
When you sell a stock to buy another stock, do you prefer to set the estimated amount of the capital gains taxes aside in a money market or do you think it better to
Saving for retirement is crucial, but relying solely on a 401(k) might not be enough due to high inflation. Consider investing in growth stocks, especially in the tec
I’m think this is not a good investment as there is no chatter at all on the 52 week low. They are involved in a class action lawsuits by investors and credit card co
Sorry if this is the wrong sub. Let’s say I had $1 million in VOO but I wanted to sell half of it to buy SCHD. It would suck to pay taxes on $500k. So how would you g
Hey guys, I did a deep dive into Crocs. In this analysis, I will do a brief breakdown of the company and go over some quantitative data, qualitative data and estimate
